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The human malaria parasite, Plasmodium falciparum, encodes a minimal complement
of six heat shock protein 70s (PfHSP70s), some of which are highly expressed and are
thought to play an important role in the survival and pathology of the parasite. In addition
to canonical features of molecular chaperones, these HSP70s possess properties that
reflect functional adaptation to a parasitic life style, including resistance to thermal insult
during fever periods and host–parasite interactions. The parasite even exports an HSP70
to the host cell where it is likely to be involved in host cell modification. This review
focuses on the features of the PfHSP70s, particularly with respect to their adaptation
to the malaria parasite life cycle.
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Introduction
Malaria rates amongst one of the major global health challenges facing developing countries, and
over half a million people die from malaria annually, 90% of which are in Africa. Plasmodium
falciparum causes the most lethal form of human malaria, and nearly all malaria deaths result from
infection by this species of Plasmodium (World Health Organisation, 2014).
HSP70 chaperones and their HSP40 co-chaperones are critical to the maintenance of cellular
proteostasis through their role in the folding, refolding, aggregation suppression, translocation,
and degradation of proteins. P. falciparum heat shock protein 70 (PfHSP70) proteins are proposed
to play a major role in parasite development and survival, particularly within the human host
(Shonhai et al., 2007, 2011; Njunge et al., 2013; Pesce and Blatch, 2014). Malaria parasites invade
human hepatocytes and erythrocytes, and have adapted to their intracellular host environment,
particularly to stresses such as the temperature fluctuations associated with febrile episodes.
Part of this adaptation has been to evolve an optimal arsenal of six PfHSP70s (Table 1), half
the number found in humans and other eukaryotic system, including other parasites (Shonhai
et al., 2011). To nevertheless allow interaction with a large array of potential substrates, it
appears that the parasite has increased its HSP40 co-chaperone complement to 49 homologs
(Botha et al., 2007; Pesce and Blatch, 2014). This suggests that the plasmodial PfHSP70–PfHSP40
chaperone system is an extreme example of HSP70 general chaperone capacity that is highly
specified through its HSP40 chaperone partners. The PfHSP70s have been more extensively
studied than the PfHSP40s, and although progress has been made in recent years, we still
know relatively little about PfHSP70–PfHSP40 partnerships (Pesce and Blatch, 2014). Five of
the PfHSP70s are located, or predicted to be located, within the parasite (PfHsp70-1, PfHsp70-
2, PfHsp70-3, PfHsp70-y, and PfHsp70-z) and one is secreted to the parasitophorous vacuole
(PV) and further exported to the host cell (PfHsp70-x; Table 1; Figure 1). Orthologs of the five
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TABLE 1 | Accession numbers, localization, and properties of P.
falciparum HSP70 homologs.
Protein PlasmoDB
accession
Localization Properties
PfHsp70-1 PF3D7_0818900 Cytosol, nucleus Protein folding and protein
aggregation suppression.
C-terminal EEVD
sequence for interaction
with PfHOP and possibly
other partners
PfHsp70-2 PF3D7_0917900 ER BiP, grp. N-terminal signal
sequence and C-terminal
ER retrieval sequence.
Translocation of proteins
into the ER and retrograde
translocation of proteins
for degradation
PfHsp70-3 PF3D7_1134000 Mitochondria? Predicted N-terminal
mitochondrial transit
peptide. Translocation of
proteins into the
mitochondrion?
PfHsp70-x PF3D7_0831700 PV, host cell N-terminal signal
sequence and non-PEXEL
export sequence.
C-terminal EEVN.
Associated with J-dots.
Trafficking of specialized
virulence proteins
PfHsp70-y PF3D7_1344200 ER? HSP110, likely NEF for
PfHsp70-2. N-terminal
signal sequence and
C-terminal ER retrieval
sequence
PfHsp70-z PF3D7_0708800 Cytosol? HSP110, likely NEF for
PfHsp70-1. Suppression
of the aggregation of
asparagine repeat-rich
proteins
BiP, immunoglobulin binding protein; ER, endoplasmic reticulum; grp, glucose regulated
protein; Hop, HSP70/HSP90 organizing protein; NEF, nucleotide exchange factor; PEXEL,
Plasmodium export element; PV, parasitophorous vacuole.
parasite-resident PfHSP70s are found in all Plasmodium species,
and very likely play a fundamental role in proteostasis of
the subcellular compartments that they occupy. In contrast,
PfHsp70-x is only found in those Plasmodium species with
highly expanded exportomes (P. falciparum and P. reichenowi),
suggesting a specialized function in protein trafficking or folding
(Külzer et al., 2012). This review focuses on the chaperone
properties of the six PfHSP70s, particularly with respect to their
adaptation to the malaria parasite life cycle.
Proteostasis of the Cytoplasm and the
Nucleus: PfHp70-1 and PfHsp70-z
The parasite resident PfHsp70-1 exhibits key features that
suggest that it is uniquely adapted to provide cytoprotection
under stressful conditions such as febrile episodes. In particular,
PfHsp70-1 has a thermostable C-terminal domain that is
proposed to stabilize the overall conformation of the protein
(Misra and Ramachandran, 2009), making it more thermostable
than the human HSP70. Furthermore, it has the properties of
a typical molecular chaperone (Matambo et al., 2004; Ramya
et al., 2006) and has been shown using in vitro assays (Shonhai
et al., 2008; Cockburn et al., 2011) and in vivo assays in bacteria
(Shonhai et al., 2005) and yeast (Bell et al., 2011) to be efficient
at suppressing protein aggregation. There are high levels of
this molecular chaperone throughout the erythrocytic stages of
the parasite life cycle (Acharya et al., 2009), with increased
levels at febrile temperatures (Kumar et al., 1991; Joshi et al.,
1992; Pesce et al., 2008). The localization of PfHsp70-1 to the
parasite nucleus and cytosol (Table 1; Figure 1; Kumar et al.,
1991; Pesce et al., 2008) suggests that it is an agent of proteostasis
within these subcellular compartments. In addition, PfHsp70-1
could be important in keeping certain proteins in an unfolded
translocation-competent state; such as proteins destined for the
mitochondria. There are eight cytoplasmic PfHSP40s (Njunge
et al., 2013), and there is experimental evidence for an interaction
of PfHsp70-1 with Pfj4 (PF3D7_1211400; Pesce et al., 2008),
PfHsp40 (PF3D7_1437900; Botha et al., 2011), and PFB0595w
(PF3D7_0213100; Njunge et al., 2015). The other cytoplasmic
PfHSP40s include proteins predicted to be ribosome-associated,
membrane-associated and involved in diphthamide biosynthesis
(Njunge et al., 2013). Therefore, a range of different unrelated
protein substrates could potentially be delivered to PfHsp70-1
through these cytoplasmic co-chaperones.
PfHsp70-z belongs to the HSP110 family and is likely
to act as a nucleotide exchange factor for PfHsp70-1. The
protein has recently been shown to be essential for parasite
viability, and there is evidence that it is able suppress the
aggregation of asparagine repeat-rich proteins more efficiently
than its eukaryotic orthologs (Muralidharan et al., 2012).
Proteins containing asparagine repeats are prone to aggregation,
and the proteome of the malaria parasite is rich in these
proteins. PfHsp70-z may have evolved to protect the malaria
parasite against the harmful effects of these proteins during
febrile episodes, and this is supported by the recent finding
that, similarly to PfHsp70-1, PfHsp70-z is also a thermostable
molecular chaperone (Zininga et al., 2015). Therefore, PfHsp70-1
and PfHsp70-z together ensure that proteostasis is maintained in
the parasite cytoplasm (Table 1; Figure 1).
Protein Secretion and Degradation:
PfHsp70-2/PfBiP and PfHsp70-y
Proteins bearing a hydrophobic N-terminal signal sequence
are routed via the endoplasmic reticulum (ER) to the PV
(Adisa et al., 2003), unless they possess further targeting signals
(Deponte et al., 2012). The ER-based HSP70, PfHsp70-2 (also
called P. falciparum immunoglobulin binding protein, PfBiP; and
P. falciparum glucose regulated protein, Pfgrp; Kumar et al.,
1988, 1991; Kumar and Zheng, 1992) has not been extensively
studied, but is very likely to be involved in protein secretion
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FIGURE 1 | The location and function of the six PfHSP70s in P.
falciparum-infected erythrocytes. PC, parasite cytosol; PPM, parasite
plasma membrane; PV, parasitophorous vacuole; PVM, parasitophorous
vacuolar membrane; RBCC, red blood cell cytosol; EM, external milieu;
N, nucleus; M, mitochondrion; ER, endoplasmic reticulum; MC, Maurer’s
cleft; K, knob; A, apicoplast; Hs70, human HSP70. All other HSP70s are
parasite encoded and labeled as in Table 1. Likely functions at specific
cellular localizations are noted by white roman numerals: (i) general
proteostasis in the nucleus by 70-1; (ii) general proteostasis in the parasite
cytosol by 70-1; (iii) involvement of 70-1 as part of a guidance complex
for mitochondrial proteins; (iv) involvement of 70-3 in translocation across
mitochondrial membranes followed by protein folding; (v) potential
involvement of 70-1 in post-translational ER targeting of secretory
proteins; (vi) involvement of 70-2 in protein translocation across PfSec61,
followed by general protein quality control via the unfolded protein
response; (vii) 70-y is likely to function as a NEF for 70-2; (viii) 70-z is
likely to function as a NEF for 70-1 and has been shown to be involved
in stabilization of asparagine-rich proteins; (ix) 70-x may be involved in
maintaining proteins in an unfolded state prior to passage across PTEX in
combination with PfHsp101, and also folding of PV resident proteins; (x)
both 70-x and Hs70 may be involved in translocation through PTEX
followed by protein folding and; (xi) insertion into the Maurer’s clefts,
knobs and erythrocyte plasma membrane. Many of the above processes
are likely to require co-chaperone activity provided by various PfHSP40s.
and degradation processes associated with the ER (Table 1;
Figure 1). Similarly to PfHsp70-1, PfHsp70-2 has been shown
to exhibit chaperone properties. Using in vitro assays PfHsp70-
2 was found to protect alcohol dehydrogenase and glutamate
dehydrogenase from thermally-induced unfolding (Ramya et al.,
2006). PfHsp70-2 and associated co-chaperones (e.g., the
membrane bound PfHSP40, PfSec63/PF3D7_1318800) have been
proposed to be involved in the secretory pathway, working closely
with the translocon machinery (PfSec61 complex; Tuteja, 2007).
Analysis of the components of the PfSec61 complex suggests the
existence of a signal recognition particle-based co-translational
ER translocation mechanism, similar to the mammalian system
(Zimmermann and Blatch, 2009); however, a post-translational
mechanism cannot be excluded. ER proteins misfolded beyond
repair are probably removed by retrograde translocation, possibly
using components of the ER-associated protein degradation
pathway (ERAD), which have previously been identified in the
parasite (Spork et al., 2009). PfHsp70-2 may work together
with an ER-luminal PfHSP40 (e.g., Pfj2/PF3D7_1108700; Botha
et al., 2007; Pesce et al., 2010) in such a quality control
process, similar to the human BiP-ERdj5 system (Hagiwara
and Nagata, 2012). PfHsp70-y, similar to PfHsp70-z, belongs
to the HSP110 family, and is thus likely to function as a
NEF for PfHsp70-2. Although this protein contains a predicted
apicoplast targeting signal, it also contains a C-terminal ER
retrieval sequence which seems to be dominant (Heiny et al.,
2012). Thus, it appears unlikely that this protein is actually
targeted to the apicoplast, but is rathermore likely to be ER
localized.
Import into Organelles: PfHsp70-3
Plasmodium parasites contain both a mitochondrion and a
secondary plastid, referred to as the apicoplast. Protein import to
these compartments is post-translational, and thus proteins must
be kept in an unfolded state prior to membrane translocation.
In other systems, organellar HSP70s provide assistance in
this process. Indeed, P. falciparum is predicted to encode a
mitochondrial HSP70, PfHsp70-3 (Njunge et al., 2013; Table 1;
Figure 1). Although not yet experimentally addressed, it is
likely that cytosolic PfHsp70-1 also contributes to mitochondrial
protein import, possibly as part of a chaperoning guidance
complex which keeps proteins in a translocation competent state
prior to passage across the mitochondrial membranes. Based on
other systems, it is likely that PfHsp90 and Pf14-3-3 are also part
of this complex.
Several studies have suggested that PfHSP70s may also play
a role in transport of proteins to the apicoplast, a secondary
endosymbiotic organelle which is related to chloroplasts (Foth
et al., 2003; Misra and Ramachandran, 2009). However, so far no
evidence has verified the presence of a HSP70 homolog within the
apicoplast. As all other PfHSP70 homologs have been localized
to other cellular compartments, it seems unlikely that PfHSP70s
play a direct role in translocation across apicoplast membranes.
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Nevertheless, the observation that inhibitors of HSP70 cause
a delay in apicoplast protein transport (Ramya et al., 2006)
suggests that possibly PfHsp70-2 (PfBiP) may be involved in
chaperoning client proteins prior to passage across the SELMA
(symbiont-derived ERAD-like machinery) translocon which is
believed to be the gateway to the apicoplast (Hempel et al., 2007;
Spork et al., 2009). This interpretation is supported by studies in
the related apicomplexan, Toxoplasma gondii, which identified
TgBiP as an important trans factor in protein targeting to the
apicoplast (Yung et al., 2003). Although as yet unproven, it has
been suggested that apicoplast targeted HSP60 (cpn60; GroEL)
or HSP100 (ClpC) may have taken over the function of HSP70 in
protein translocation across the multiple apicoplast membranes
(Sato, 2011). If this is true, it represents a fascinating evolutionary
example of a parasite “losing” one chaperone and co-opting
another to take over its function.
Protein Export: PfHsp70-x
P. falciparum is predicted to export over 450 proteins (8% of
the entire proteome) into the human erythrocyte where they are
involved in modifications of the host cell which are essential for
parasite survival (Hiller et al., 2004; Marti et al., 2004; Sargeant
et al., 2006; Maier et al., 2008). The protein export pathway
involves: (i) entry into and transit through the ER; (ii) secretion
into the PV; (iii) translocation across the parasitophorous
vacuolar membrane (PVM) into the erythrocyte; (iv) trafficking
of soluble proteins to their final destination in the cytosol; or
(v) trafficking of membrane proteins in complexes or through
vesicular networks to the Maurer’s Clefts and to the plasma
membrane of the erythrocyte (Deponte et al., 2012; Figure 1).
Therefore, any exported parasite protein must cross a number
of different membranes in an unfolded translocation-competent
conformation by a process that will very likely require molecular
chaperones at all stages. Two classes of exported proteins have
been identified. One class contains a so-called Plasmodium
export element or host targeting (PEXEL/HT) motif downstream
of an N-terminal ER-type hydrophobic signal sequence. The
PEXEL/HT motif is cleaved in the ER (Chang et al., 2008;
Boddey et al., 2010; Russo et al., 2010) and (in a process not
yet understood) directs proteins into an export pathway to the
host cell. Another class of proteins, so called PEXEL Negative
Exported Proteins (PNEPs) do not contain any recognizable
conserved export motif, and indeed often do not contain an
N-terminal ER-type signal sequence (Spielmann and Gilberger,
2010; Heiber et al., 2013). A notable member of the PNEPs
is P. falciparum erythrocyte membrane protein 1 (PfEMP1)
which is transported to the host cell plasma membrane, and
that is directly implicated in malaria pathology by a process
called cytoadherance. Despite divergence in the signals mediating
export, the export pathway of PEXEL and PNE proteins appears
to converge at a protein translocon within the PVM, referred
to as PTEX (Plasmodium translocon of exported proteins; de
Koning-Ward et al., 2009; Gruring et al., 2012). Thus, down-
regulation or functional interruption of a PTEX component leads
to a transport block of both PEXEL and PNE proteins (Beck
et al., 2014; Elsworth et al., 2014). Additionally, inhibition of
protein unfolding also leads to a transport block of both protein
classes in the PV (Gehde et al., 2009; Gruring et al., 2012).
Recently, PfHsp70-x was shown to be localized to both the PV
and host cell cytosol (Table 1; Figure 1). Within the host cell
cytosol, PfHsp70-x could be localized to small punctate structures
known as J-dots (Külzer et al., 2012). These structures are motile
within the host cytosol, and have also previously been shown
to contain PfEMP1 (Külzer et al., 2010). Thus, the possibility
exists that PfHsp70-x is involved in protein traffic both (a)
across the PV, possibly as an associated factor of the PTEX
translocon, and (b) within the host cell cytosol, possibly as part
of a chaperoning complex to carry proteins to their final sub-
cellular localization. A role for PfHsp70-x within the PV would
make sense, as the PTEX translocon is partially composed of
PfHsp101, a molecular chaperone known (in other systems) to
often functionally associate with HSP70s. Alternatively, in the
PV PfHsp70-x may be involved in keeping exported proteins
unfolded prior to passage across the PVM via PTEX. Once
proteins reach the trans side of the PVM, they need to be
folded and transported to their final destination. PfHsp70-x may
be involved in this process, as may residual human HSP70s.
Additionally, PfHsp70-x may be required to chaperone larger
proteins complexes through the erythrocyte cytosol, and assist in
their insertion into either the Maurer’s clefts, or host cell plasma
membrane. Of note, PfHsp70-x is only encoded by parasite
species which export EMP1-like proteins, suggesting that it may
play a special role in export of this specialized (but highly
important) protein family (Külzer et al., 2012).
PfHSP40s
Although this review concentrates on PfHsp70s, it would be
unwise not to comment on the HSP40s. HSP40s function as
co-chaperones for HSP70s and are involved in specificity of
substrate recognition and stimulation of HSP70 ATP hydrolysis
activity. Of all the parasite-resident PfHSP40s, so far only Pfj4
has been captured in a common complex with PfHsp70-1 using
immunoprecipitation assays (Pesce et al., 2008). Interestingly,
there is evidence from gel filtration studies that PfHsp70-1 may
occur in two distinct complexes, one with Pfj4 and another
with PfHsp90 (Pesce et al., 2008). This PfHsp90–PfHsp70-1
complex may include and be functionalized by P. falciparum
HSP70/HSP90 organizing protein (PfHOP) (Gitau et al., 2012).
Amazingly, in addition to exporting PfHsp70-x, P. falciparum
may export almost half (23) of its expanded complement of
49 HSP40s (Sargeant et al., 2006; Botha et al., 2007). Although
the exact nature of PfHSP70–PfHSP40 pairings has yet to be
investigated in detail, localization data suggests that at least
two of the exported PfHSP40s colocalize and are found in
a complex with PfHsp70-x and thus may by involved in
regulating PfHsp70-x function (Külzer et al., 2012). Several other
exported HSP40s have been implicated in host cell modification,
including biogenesis of knob structures under the surface of
the erythrocyte, insertion of PfEMP1 into these structures and
alteration of erythrocyte stiffness, all features which are likely
to have a direct effect on pathogenicity of parasites in the
human host (Maier et al., 2008). It is however not yet known
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whether these proteins carry out their function mainly in
conjunction with PfHsp70-x, or possibly together with residual
human HSP70 which is found in high concentrations within the
host cell, a fascinating area of research which deserves further
study. A recent publication suggests that exported HSP40s may
be able to functionally associate with both PfHsp70-x and
human HSP70, further increasing the flexibility of the potential
chaperone-cochaperone pairing (Hatherley et al., 2014). So far,
in silico data suggest that P. falciparum has evolved to use a
minimal complement of PfHSP70s, supported by an expanded
HSP40 complement to confer substrate specificity and diversity.
Deciphering the role and functional interactions of the expanded
PfHSP40 complement will allow us a window into understanding
this evolutionary flexibility.
PfHSP70s as Drug Targets
Although counter-intuitive due to the high sequence
conservation amongst members of the HSP70 family from
highly divergent organisms, they may actually be specially
suited as drug targets. Such highly conserved proteins are
often essential for cell survival, a key factor for any potential
drug target. Furthermore, these proteins evolve considerably
slower than non-conserved protein families, leading to less
variation under drug selection pressure, and hence less chance
of the emergence of drug resistance (Edkins and Blatch, 2012).
However, there is sufficient structural and functional variation
among HSP70s of different origins, for them to be specifically
inhibited (Shonhai et al., 2007; Pesce et al., 2010; Shonhai, 2010).
Due to interest in their potential as anti-cancer medication, a
growing number of HSP70 inhibitors are being made available.
Indeed, certain features of HSP70s make them amenable to
functional inhibition (and hence druggable): such as their ability
to bind small molecules that can be readily detected in simple
assays (e.g., ATP); and their association with regulatory factors
(e.g., ATP hydrolysis stimulation by HSP40s) whose inhibition
has detectable functional consequences. A number of different
compound classes have been identified as modulators of HSP70
activity, including ATP mimics, spergualins, pyrimidinones,
and peptides (Zininga and Shonhai, 2014). PfHsp70-1 has also
been found to be modulated by a number of different classes of
small molecules. Pyrimidinones have been shown to significantly
inhibit the ATPase activity of PfHsp70-1 as well as the in vitro
growth of the malaria parasite (Chiang et al., 2009). Further
studies on these pyrimidinones have shown that they are able to
modulate both the basal and HSP40-stimulated in vitro ATPase
activities of PfHsp70-1 (Botha et al., 2011). PfHsp70-1 and
PfHsp70-x are able to efficiently suppress the aggregation of
an aggregation-prone model substrate (malate dehydrogenase)
in a thermal denaturation-based assay (Cockburn et al., 2011,
2014). A number of natural product compounds showing
anti-plasmodial activity were found to selectively modulate the
in vitro protein aggregation suppression activity of PfHsp70-
1 (1,4-naphthoquinones and marine prenylated alkaloids
or malonganenones; Cockburn et al., 2011). Some of these
compounds were also found to selectively modulate the in vitro
protein aggregation suppression activity of PfHsp70-x, as well
as the basal and HSP40-stimulated ATPase activities of both
PfHsp70-1 and PfHsp70-x, compared with human HSP70
(Cockburn et al., 2014). Therefore, PfHsp70-1 and PfHsp70-x
appear to be druggable; but a much more concerted effort in
drug discovery is needed before the first drug hits the market.
Conclusion
Although detailed functional research into the HSP70 chaperone
complement of P. falciparum is still in its infancy, we have already
begun to notice small but important differences between this
parasite and other model systems. This knowledge has already
been applied to identify small molecules which differentially
inhibit PfHSP70s compared to their human counterparts. A
deeper knowledge of the mechanistic peculiarities of PfHSP70s,
especially with regard to their HSP40 co-chaperones, is likely
to reveal further unusual features of this chaperone system
which may be amenable to drug-design strategies. To this end,
important progress is being made by recombinant expression
and purification of all the PfHSP70s and potential PfHSP40s
for functional assays. The reduced HSP70 complement of the
parasite suggests that certain members have evolved to carry
out a larger number of functions than their orthologs in other
species. This may represent a “chaperone bottleneck” which can
be targeted by selective inhibitor design.
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